Hemoglobin

Papers
(The TQCC of Hemoglobin is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Long Non-Coding RNA H19 Leads to Upregulation of γ-Globin Gene Expression during Erythroid Differentiation24
Clinical Exome Sequencing Reveals Novel Mutations in SPTB Gene Associated with Hereditary Spherocytosis in Patients with Suspected Congenital Hemolytic Anemia20
Identification of a New δ chain hemoglobin Variant, Hb A2-Malay [δ46(CD5)Gly > Arg, HBD : C.139G > C;316-443A > G]16
Noninvasive Prenatal Diagnosis of SEA-Thalassemia by Combining 1000 Genomes Database and Relative Haplotype Dosage11
Morbidity and Mortality Associated with COVID-19 and Acute Chest Syndrome in Sickle Cell Disease Patients10
ATG-Thymoglobulin Versus ATG-Fresenius for Conditioning in Thalassemia Patients Who Underwent Allogenic Stem Cell Transplantation from Matched-Sibling Donor: A Tertiary Cancer Care Center Short-Term E8
A Cross-Sectional Study on Pain and Quality of Life of Adult Patients with Transfusion-Dependent Thalassemia in a Tertiary Hospital In Malaysia8
Coexisting β-Thalassemia Trait, Gilbert Syndrome and Alpha-Globin Gene Triplication in a Child with Non-Transfusion Dependent Thalassemia Phenotype7
Identification of Sickle Cell Disease and Its Associated Other Structural Variants of Hemoglobin Using High Performance Liquid Chromatography and Their Clinical Profiling7
Splice Acceptor Mutation [ HBB :c.93-2A > T] in a Patient with Hb S/β 0 -Thalassemia7
The First Iranian Case of Unstable Hemoglobin Santa Ana7
Effect of Hydroxyurea Therapy on Growth Parameters in Older Children (6-15 Year-Old) with Sickle Cell Disease: Low Dose Versus High Dose6
Research Progress of Cell-Free Fetal DNA in Non-Invasive Prenatal Diagnosis of Thalassemia6
Inflammatory Biomarkers in Sickle Cell Disease: Understanding Their Role in Predicting the Disease-Related Complications6
A novel α Globin Gene Cluster Duplication, αααα380 Heterozygous β0-Thal Variant, Leading to a Blood Transfusion-Dependent Phenotype6
Strengthening Health System and Community Mobilization for Sickle Cell Disease Screening and Management among Tribal Populations in India: An Interventional Study6
Submitting Novel Globin Gene Variants to Hemoglobin5
Comparison of Sickle Solubility Test with Mass Spectrometry for Hemoglobin S Confirmation5
Coexistence of Mycoplasma Pneumonia and Pulmonary Embolism as a Cause of Acute Chest Syndrome in a Child with Sickle Cell Disease5
Gene Therapies for Hemoglobinopathies: Promises and Challenges5
A Review of Gene Therapies for Hemoglobinopathies4
Molecular Identification and the Hematological Findings of Four Novel Variants in Globin Genes in Jiangxi Province of Southern China4
Evaluation of the Function of a Rare Variant in the 3'-Untranslated Region of the β-Globin Gene4
Two Novel δ-Globin Chain Variants Identified in the Chinese Population4
A 6-Year Follow-up of a Chinese Child with Homozygous β 0 -Thalaasemia and a Heterozygous KLF1 Mutation4
Identification of a β-Globin Gene Mutation with the Genotype β-28(A > G), IVS-I-5(G > A)/βCD 71/72(+A) Using Third-Generation Sequencing4
Point-of-Care Newborn Screening for Sickle Cell Disease at Selected Health Facilities in the Gambia3
The Impact of Region-of-Interest Selection on MRI T 2 * Quantification of Hepatic Iron Overload in Thalassemia Major3
Hypercoagulability in Sickle Cell Disease: A Thrombo-Inflammatory Mechanism3
Hb Huadu [α124(H7)Ser→Thr (TCC>ACC), HBA2: c.373T>A]: A Novel Variant of the α-Globin Gene3
The Risk of Rapid Deterioration of Sepsis in the Patient with Non-Transfusion-Dependent Thalassemia: A Case Report3
Identification of a Rare β-Globin Chain Hemoglobin Variant: HBB : C.24G > C (Glu7Asp)3
Hyperbaric Oxygen Therapy in Sickle Cell Disease: A Narrative Review of Mechanisms, Clinical Applications, and Future Directions3
The Spectrum of HBB Mutations among 2315 Beta Thalassemia Patients of a Reference Clinic in Tehran-Iran3
A Rare Case of Abnormal Hemoglobin Variant Hb Mizuho: [HBB: c.206T > C β 68(E12) Leu-Pro]: A First Report in the Chinese Population3
A Hemoglobin Variant, Resulting from a Novel Missense Mutation [CD 112(G14) Cys > Ser (TGT > TCT); HBB : C.338G > C], Was Discovered by MALDI-TOF MS3
Beyond Diagnosis: A Systematic Review of Artificial Intelligence and Deep Learning in Monitoring Iron Overload and Organ Toxicity in Beta-Thalassemia3
Rapid Identification of β-Thalassemia, Hb E, and High Hb F Determinants Using a High-Resolution Melting Analysis: Application in Prenatal Diagnosis in Southern Thailand3
First Report of Hb Youngstown in Capillary Electrophoresis and Overlapping Hb Analysis Findings with Hb Rush2
HBA2 Gene Conversion Disrupts Reverse Dot-Blot Hybridization Genotyping: A Prenatal Case of Non-Deletional α-Thalassemia Misdiagnosis2
Rare Coexistence of Hemoglobin D-Iran and Hemoglobin S in a Case from Central India2
Hb Ryazan: An Elongated C‐Terminal β-Chain Due to a New Frameshift Mutation, HBB: c.396delG p.Val133Trpfs*252
Prevalence and Spectrum of β-Thalassemia Mutations in Baghdad, Iraq: Data from the Premarital Screening Program2
Current Status of β-Thalassemic Burden in India2
The Most Common Types of 3.7 Kilobase Deletion in the Iranian Population2
Polyneuropathy Associated with Age of Starting the Transfusion and Serum Ferritin Level in Iranian Patients with Thalassemia Major and Intermedia2
High Prevalence of Hb Riccarton Challenges HbA1c Analysis in a Danish Clinical Laboratory Using the Tosoh G112
“Assessing Long-Term Health-Related Quality of Life in Children with β-Thalassemia Major Following Hematopoietic Stem Cell Transplantation” – A Cross-Sectional Comparative Study2
Premarital Screening is Pivotal in Reducing the Births of Babies Affected with Thalassemia Major in Iraq2
Therapeutic Response to Hydroxyurea in Beta-Thalassemia Intermedia with Rare Mutation: A Case Report2
Comparative Analysis of Erythroferrone and Hepcidin as Emerging Biomarkers of Iron Homeostasis in Patients with β-Thalassemia Major: A Case-Control Study from Pakistan2
Prediction of Heart and Liver Iron Overload in β-Thalassemia Major Patients Using Machine Learning Methods2
miR-192-5p as a Potential Diagnostic Biomarker for β-Thalassemia and Its Regulatory Mechanism via Targeting BCL11A2
Genetically Confirmed Dual Hematologic Disorder: A Case of β-Thalassemia with Frameshift Mutation and Type 3 von Willebrand Disease in a Pediatric Patient2
Fist Detection of Hb Suqian[β42(CD1) Phe→Leu, HBB:c.129T > A] in Han Chinese2
Adherence to Iron Chelation Therapy Among Children with Beta Thalassemia Major: A Multicenter Cross-Sectional Study2
Implementation of a Dedicated Hematopoietic Stem Cell Transplant Program for Sickle Cell Disease in Lagos, Nigeria: Challenges and Opportunities2
Alpha Thalassemia Major: From a Lethal to a Treatable Condition2
Identification of a Novel Mutation in the 3′ Untranslated Region of the β-Globin Gene (HBB:c.*132C>G) in a Chinese Family2
Difficult Cases in the Diagnosis of Thalassemia Syndromes2
α- and β-Thalassemia Show Distinct Bone Microarchitectural Phenotypes in Southeast Asian Adults: Associations with Marrow Expansion Phenotype2
Dynamic Viscosity of Hemoglobin Solutions Determined by Transverse Proton Magnetic Relaxation2
A New δ-Globin Gene Variant: Hb A2-Yulin [δ46(CD5)Gly→Arg, HBD : C.139G > A]2
Evaluation of the Neuropathic Component of Pain in Sickle Cell Disease1
Ameliorating Mental Health Issues in Sickle Cell Disease Patients: A Viewpoint1
The Effect of Single Nucleotide Polymorphisms on Clinical Phenotypes of Sabahan Transfusion-Dependent β-Thalassemia Patients with Homozygous Filipino β 0 -Deletion1
Spectrum of β-Thalassemia and Other Hemoglobinopathies in the Saurashtra Region of Gujarat, India: Analysis of a Large Population Screening Program1
Successful Treatment of a Child with Hemoglobin Hammersmith with Hematopoietic Stem Cell Transplantation1
β 0 -Thalassemia Caused by a Novel Nonsense Mutation [ HBB: c.199A > T]1
Utility of Molecular Sequencing and Hematologic Parameters for Diagnosis of α-Thalassemia: A Perspective of the National Reference Laboratory1
Pyruvate Kinase Activators for Sickle Cell Disease: An Exploratory Systematic Review and Meta-Analysis1
KLF1 Knockdown Differentially Regulates γ-Globin Expression: Inhibition in K562 Cells but Reactivation in β-Thalassemia Major Erythrocytes with Erythropoiesis Disruption1
Phenotypic Analysis of the HBA2 : C.95 G > A Mutation in China1
The First Compound Heterozygosity for Two Different α-Thalassemia Determinants Causes Hb Bart’s Hydrops Fetalis in a Chinese Family1
Hypersplenism Affects Growth and Haematology in HbSS: Observations from the Jamaican Birth Cohort1
HbH Disease in an Elderly Man Due to Compound Heterozygosity for Deletional α-Thalassemia and Hb Dubai ( HBA2 :c.368A > T)1
A Novel 165 Kb Duplication Involving the α-Globin Gene Cluster Is Identified by Low-Pass Whole Genome Sequencing in a Chinese Thalassemia Intermedia Patient1
Perspectives of General Hematologists on a Proposed Shared Care Model for HSCT in Sickle Cell Disease1
Prevalence and Molecular Characterization of β-Thalassemia in Kirkuk Province of Northern Iraq1
Hereditary Hemolytic Anemia Due to PIEZO1 Red Blood Cell Membrane Defect1
Identification of a Novel Variant c.163delG in HBB Gene Resulting in a Beta Null Phenotype in a Proband with Thalassemia Intermedia1
Misdiagnosis of α-Thalassemia Heterozygotes as Homozygotes Due to Base Mutations in the Primer Binding Region1
First Case of Hb City of Hope ( HBB : c.208G > A) in Andalusia. A Molecular Update of β-Thalassemia in Southwestern Spain (Huelva Province)1
Sickling Disorder Caused by Co-Inheritance of Hemoglobin Maputo and Hemoglobin S: Case Report and Review of the Literature1
Hemoglobin β-Globin Variants In Hispanic Patients: An Institutional Experience From Dallas, Texas1
β-Thalassemia Trait Caused by a SUPT5H Defect: First Report of an Intragenic Deletion1
Hb A 2 -Getafe [δ 132 (H10) Lys > Thr, HBD : c.88C > A]: New Mutation in the δ-Globin Gene in a Spanish Patient1
Long-Term and Transient Calcium Channel Blockers; A Systematic Review of Their Role in the Management of Cardiomyopathy in Transfusion-Dependent Thalassemia1
Beyond Hypersplenism: Splenic Marginal Zone Lymphoma in an Older Adult with Hemoglobin E/Beta-Thalassemia1
A Novel Frameshift Mutation( HBA2 :C.337delC) Associated With α-Thalassemia Trait Detected by Next-Generation Sequencing in Southern China1
Diagnosis and Treatment of Alpha Thalassemia Major1
Prevalence and Molecular Characteristics of Hemoglobin Variants in Laibin City, Central Guangxi of Southern China1
A New Hemoglobin Variant: Hb Tangshan [ HBA1 : c.239C > T, CD79(GCG > GTG)(Ala > Val)] Detected by MALDI-TOF MS1
Hb A 2 -Pontedera [δ93(F9) Cys > Trp; HBD : C.282T > G]: A New δ-Globin Chain Variant Detected by Screening Tests for Hemoglobin1
Risk Factors for Anemia in Silent Carrier or Minor α-Thalassemia1
Hb Yongning [β1 (NA1) Val→Leu; HBB :C.4G > C]: A Novel Hemoglobin Variant Causing Significant Interference in Common Glycated Hemoglobin Assays1
Existing Tubular Injury in β-Thalassemia Major Patients Receiving Iron Chelating Agents with Normal Creatinine Level in East Java, Indonesia1
A Rare Severe Hemolytic Crisis in Homozygous Hemoglobin E (HbEE)1
Rare Case of Homozygosity for CYB5R3 Variant c.235C > T p.(Arg79Trp) Causing Type II Methemoglobinemia1
Mild Thalassemic Effect of Heterozygous Hb Sogn in a Large Cohort from Routine Hemoglobinopathy Investigation1
Severe Hb H Disease Caused by Hb Zürich–Albisrieden (HBA1: c.178G>C): Another Case Report1
Comparative Study of Ferritin Levels between Two Generic Formulations of Deferasirox in Sri Lankan Patients with Beta-Thalassemia Major1
A Rare Case of De Novo α-Globin Cluster Duplication, ααα 102 (NC_000016.10: G.79903_181947dup) in a β-1
Hb Nivaria: A New Hemoglobin Variant with a Shortened α-Globin Chain [α139(HC1)LysStop; HBA1: c.418A>T]1
Knowledge of Sickle Cell Disease, Awareness of Sickle Cell Trait Status and Its Impact on Relationships Among Students at a Historically Black College1
The First Thai Case of Nondeletional HbH Disease Caused by Compound Heterozygosity for α-Thalassemia-1 Chiang Rai (-- CR ) Type Deletion with Hb Constant Spring1
Kinetic Characterisation of the R and R2 Quaternary Structures of Oxyhemoglobins Arising from Different Effects of Inositol Hexakisphosphate on Their Reactions with Ellman’s Reagent1
A Novel β-Globin Variant, Hb Odder [ HBB : C.316C > G; CD105 (Leu > Val)]1
Targeted Next-Generation Sequencing Reveals a Large Novel β-Thalassemia Deletion that Removes the Entire HBB Gene1
SickleInAfrica Consortium: A Seven-Country Study Evaluating the Performance of Dried Blood Spot Point-of-Care Testing in Newborn Screening for Sickle Cell Disease1
Sociodemographic and Clinical Factors Predictive of Poor Health-Related Quality of Life of Children with Sickle Cell Anemia in The Gambia1
Poor Sleep Quality in Jamaican Adults With Sickle Cell Disease: Prevalence, Risk Factors, and Association With Quality of Life1
Nonsense Variant in the β-Spectrin Gene Causing Hereditary Spherocytosis Identified by Whole-Exome Sequencing in a Child1
Hb F-SickKids ( HBG2 : C.308A > G): A Novel γ-Globin Variant Associated with Transient Neonatal Cyanosis1
Estimating the Cost of Thalassemia Care across the World: A Thalassemia International Federation Model1
Haplotype-Specific Genetic Epidemiology of Sickle Cell Anemia Patients in Accra, Ghana: Patterns, Clinical Implications, and Public Health Responses1
Sickle Cell Disease in Brazil: Current Management1
Silent Cerebral Infarcts in Iraqi Patients with Sickle Cell Disease1
Efficacy and Safety of a Dispersible Tablet of GPO-Deferasirox Monotherapy among Children with Transfusion-Dependent Thalassemia and Iron Overload1
A Rare Hemoglobin Variant Detected for the First Time in Türkiye (Hb Iraq-Halabja): Evaluation of the Effect of Variant Hemoglobins on HbA1c Methods1
A Novel Hemoglobin Variant, Hb Hefei [CD113(GTG > GGG)(Val > Gly); HBB :c.341T > G], Was Detected by Matrix-Assisted Laser Desorption/Ionization1
Pituitary Versus Hepatic Iron Assessment in Transfusion-Dependent Thalassemia: Is Signal Intensity Ratio a Reliable Tool?1
Encouraging Outcomes of Hematopoeitic Stem Cell Transplantation in Pediatric Sickle Cell Disease- A Decade-Long Experience from the Developing World1
0.065885782241821